Abstract
AbstractHigh rates of cigarette smoking have been observed in pregnant women on opioid agonist therapy (OAT). However, it is unclear if these rates have changed overtime in line with the general population and the degree to which smoking contributes to poor outcomes in neonates born to women on OAT. Women who gave birth in Western Australia (WA) between 2003 and 2018 were identified from whole-population midwives records. Linked records were used to identify women who had been dispensed OAT during pregnancy and those who had smoking during pregnancy. Temporal changes in smoking during pregnancy were examined for women on OAT (n = 1059) and women not on OAT (n = 397,175) using Joinpoint regression. In women treated with OAT during pregnancy, neonatal outcomes were compared between smoking and non-smoking women using generalised linear models. During the study period, 76.3% of women on OAT smoked during pregnancy compared with 12.0% of the general population. There was a decrease in the prevalence of smoking during pregnancy among women not on OAT (APC: − 5.7, 95%CI: − 6.3, − 5.2), but not in women on OAT (APC: 0.8, 95%CI: − 0.4, 2.1). For women receiving OAT, smoking was associated with an increased odds of low birth weight (OR: 1.57, 95%CI: 1.06, 2.32) and neonatal abstinence syndrome (OR: 1.34, 95%CI: 1.01, 1.78) compared with non-smoking. Despite reductions in the prevalence of smoking during pregnancy in the general population, similar reductions have not occurred in pregnant women on OAT. The high prevalence of smoking in pregnant women on OAT is contributing to poor neonatal outcomes.
Funder
University of Western Australia
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Obstetrics and Gynecology
Reference38 articles.
1. Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT, Crozier S, Godfrey KM, Hindmarsh P, Vik T, Jacobsen GW, Hanke W, Sobala W, Devereux G, Turner S (2017) A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS One 12(2):e0170946
2. ABS (2013) Socio-Economic indexes for areas, ABS cat. No. 4906.0. Australian Bureau of Statistics. Canberra
3. Anon (2018) Clinical guidance for treating pregnant women and partenting women with opioid use disorder and their infants. S. A. a. M. H. S. Administration, Rockville, MD
4. Anon (2022) Australia’s mothers and babies. AIHW, Canberra
5. Arnaudo CL, Andraka-Christou B, Allgood K (2017) Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment. Curr Addict Rep 4(1):1–13